Physician profile
Matthew E Fox
NPI 1629459706
$1,510.62
in general payments reported to CMS, 2019-2025
20 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $51.91 · 2023: $414 · 2024: $756 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,439 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.71 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $265.90 | 2023-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $172.99 | 2023-2024 | Xarelto |
| Boston Scientific Corporation | $164.69 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $127.08 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Medtronic, INC. | $120.47 | 2022-2025 | Mvp, Abre |
| Astrazeneca Pharmaceuticals LP | $120.27 | 2023-2025 | Brilinta, Tagrisso, Wainua |
| Novartis Pharmaceuticals Corporation | $113.39 | 2023-2025 | |
| Tactile Systems Technology INC | $79.46 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bayer Healthcare Pharmaceuticals INC. | $54.52 | 2024-2025 | |
| Pfizer INC. | $39.94 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $38.33 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.52 | 2023-2024 | Jardiance |
| Lemaitre Vascular, INC. | $31.34 | 2024 | Trivex System |
| Edwards Lifesciences Corporation | $28.67 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $28.32 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.19 | 2023 | Mitraclip |
| Alcresta Therapeutics, INC. | $18.81 | 2025 | Relizorb |
| Sanofi-Aventis U.S. LLC | $18.45 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.92 | 2024 | Lifevest |
| Aroa Biosurgery Incorporated | $17.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.